Coronavirus live updates: At 1,808,550, Maharashtra has the highest number of coronavirus cases, followed by Karnataka 879,560, Andhra Pradesh 865,000, Tamil Nadu 776,174 and Kerala 583,000
Covid may impact vision of some patients, ethical dilemma of denying vaccine to trial participants, UP artisans start selling online-news relevant to India's fight against the pandemic
The active Covid-19 caseload in India stands at 4,55,555 on Friday which is 4.89 per cent of the total cases
Russia's sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year of Russia's Covid vaccine Sputnik V, in India
Russia's sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19
The union territory of Puducherry registered 16 fresh Covid-19 cases taking the overall tally to 36,856, a top Health department official said
Prime Minister Narendra Modi is scheduled to visit vaccine maker Bharat Biotech's facility here on Saturday, the Telangana Chief Secretary Somesh Kumar said
Jharkhand's COVID-19 caseload rose to 108,388 as 230 more people tested positive for the infection, a health official said on Friday
AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage amid questions over the results from its late-stage study
Russia said its Sputnik V vaccine is 92% effective at protecting people from COVID-19, according to interim trial results
Coronavirus live updates: At 1,802,365, Maharashtra has the highest number of coronavirus cases, followed by Karnataka 878,055, Andhra Pradesh 864,000, Tamil Nadu 774,710 and Kerala 571,000
SII is unlikely to announce any interim data from the trials here. It will wait to compile and analyse data, before sharing it with the Indian regulator.
Rao had also informed that ambassadors and envoys from 100 countries will visit the Serum Institute of India and the Gennova Biopharmaceuticals Ltd here on December 4
Seroconversion was also documented among individuals without a history of known contact with a COVID-19 case, and among those without any prior SARS-CoV-2 testing
The court was hearing a PIL by advocate Rakesh Malhotra seeking increase in the COVID-19 testing numbers in the national capital and getting speedy results
Maharashtra's Covid-19 case count on Thursday crossed 18 lakh to reach 18,02,365 as 6,406 new infections came to light, a health official said.
Serum Institute of India said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly
The positivity rate was 8.65 per cent. It was 8.49 per cent on Wednesday.
Serum Institute has partnered with global pharma giant AstraZeneca and the Oxford University
Experts said that Delhi has sufficient infrastructure and equipment to effectively cover its entire population.